Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Sex-related differences in risk factors, outcome, and quality of life in patients with permanent atrial fibrillation: results from the RACE II study.

Kloosterman M, Crijns HJGM, Mulder BA, Groenveld HF, Van Veldhuisen DJ, Rienstra M, Van Gelder IC.

Europace. 2019 Nov 20. pii: euz300. doi: 10.1093/europace/euz300. [Epub ahead of print]

PMID:
31747018
2.

Lenient vs. strict rate control in patients with atrial fibrillation and heart failure: a post-hoc analysis of the RACE II study.

Mulder BA, Van Veldhuisen DJ, Crijns HJ, Tijssen JG, Hillege HL, Alings M, Rienstra M, Groenveld HF, Van den Berg MP, Van Gelder IC; RACE II investigators.

Eur J Heart Fail. 2013 Nov;15(11):1311-8. doi: 10.1093/eurjhf/hft093. Epub 2013 Jun 12.

3.

Rate control in atrial fibrillation, insight into the RACE II study.

Groenveld HF, Crijns HJ, Tijssen JG, Alings M, Hillege HL, Tuininga YS, Van den Berg MP, Van Veldhuisen DJ, Van Gelder IC.

Neth Heart J. 2013 Apr;21(4):199-204. doi: 10.1007/s12471-013-0391-1. No abstract available.

4.

Rate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation).

Groenveld HF, Tijssen JG, Crijns HJ, Van den Berg MP, Hillege HL, Alings M, Van Veldhuisen DJ, Van Gelder IC; RACE II Investigators.

J Am Coll Cardiol. 2013 Feb 19;61(7):741-8. doi: 10.1016/j.jacc.2012.11.038.

5.

The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study.

Groenveld HF, Crijns HJ, Van den Berg MP, Van Sonderen E, Alings AM, Tijssen JG, Hillege HL, Tuininga YS, Van Veldhuisen DJ, Ranchor AV, Van Gelder IC; RACE II Investigators.

J Am Coll Cardiol. 2011 Oct 18;58(17):1795-803. doi: 10.1016/j.jacc.2011.06.055.

6.

Effect of lenient versus strict rate control on cardiac remodeling in patients with atrial fibrillation data of the RACE II (RAte Control Efficacy in permanent atrial fibrillation II) study.

Smit MD, Crijns HJ, Tijssen JG, Hillege HL, Alings M, Tuininga YS, Groenveld HF, Van den Berg MP, Van Veldhuisen DJ, Van Gelder IC; RACE II Investigators.

J Am Coll Cardiol. 2011 Aug 23;58(9):942-9. doi: 10.1016/j.jacc.2011.04.030.

7.

Rate Control in Atrial Fibrillation.

Van Gelder IC, Groenveld HF.

Card Electrophysiol Clin. 2010 Sep;2(3):419-427. doi: 10.1016/j.ccep.2010.07.004.

PMID:
28770800
8.

Lenient versus strict rate control in patients with atrial fibrillation.

Van Gelder IC, Groenveld HF, Crijns HJ, Tuininga YS, Tijssen JG, Alings AM, Hillege HL, Bergsma-Kadijk JA, Cornel JH, Kamp O, Tukkie R, Bosker HA, Van Veldhuisen DJ, Van den Berg MP; RACE II Investigators.

N Engl J Med. 2010 Apr 15;362(15):1363-73. doi: 10.1056/NEJMoa1001337. Epub 2010 Mar 15.

9.

Does intensity of rate control influence outcome in persistent atrial fibrillation? Data of the RACE study.

Groenveld HF, Crijns HJ, Rienstra M, Van den Berg MP, Van Veldhuisen DJ, Van Gelder IC; RACE investigators.

Am Heart J. 2009 Nov;158(5):785-91. doi: 10.1016/j.ahj.2009.09.007.

PMID:
19853699
10.

Erythropoietin treatment in patients with chronic heart failure: a meta-analysis.

van der Meer P, Groenveld HF, Januzzi JL Jr, van Veldhuisen DJ.

Heart. 2009 Aug;95(16):1309-14. doi: 10.1136/hrt.2008.161091. Epub 2009 Jan 23. Review.

PMID:
19168472
11.

Anemia and mortality in heart failure patients a systematic review and meta-analysis.

Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, van der Meer P.

J Am Coll Cardiol. 2008 Sep 2;52(10):818-27. doi: 10.1016/j.jacc.2008.04.061. Review.

Supplemental Content

Loading ...
Support Center